Effective sustainability strategies in pharma supply chains reduce rework and overage. Three leakage points offer the most practical starting point for rooting out waste.
- Regulatory Readiness In Clinical Supply: Building A Culture Of Compliance, Part 1
- Optimizing Clinical Trial Supply Chains For Epidemic Response
- The High Cost Of Zero Waste: Protecting Patients In Clinical Supply
- From Crisis Response To Repeatable Resilience In Clinical Supply
- Transitioning Into A Clinical Trial Supply Chain Study Lead Role
- U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact
- Beyond The AI Hype: Prompt Engineering In Clinical Trial Supply
- Active Versus Passive Shipping Solutions For Clinical Shipments
ON-DEMAND WEBINARS
Join patient-centric supply chain expert Marco Hogenboom for a discussion on how to accelerate the delivery of advanced therapies in an unpredictable environment through supply chain customization from clinical to commercialization.
Gain a deeper understanding of current directives and metrics to equip your team with the knowledge necessary to navigate the evolving landscape of sustainability.
Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.
With so many moving parts in a clinical trial, why worry about the technology that is supposed to help manage it? In this webinar, explore five actionable and necessary strategies to leverage RTSM to simplify clinical trial operations.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1180780708 health]( "Benefits Of Implementing EDC & Medical Coding With RTSM")
Benefits Of Implementing EDC & Medical Coding With RTSMDiscover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.
-
![Refrigerated Container cold chain]( "Transportation Solutions For Cell And Gene Therapy Supply Chains")
Transportation Solutions For Cell And Gene Therapy Supply ChainsDeveloping a strong supply chain for your cell and gene therapy can make your company a more attractive target for acquisition as well as a more competitive player in the commercial environment.
-
![GettyImages-2170642314-year 2025]( "What Does 2025 Hold For Pharma?")
What Does 2025 Hold For Pharma?Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.
-
![03 West]( "Sample Sizes For Performance Testing Of Combination Products, Packaging")
Sample Sizes For Performance Testing Of Combination Products, PackagingWhen developing combination products or evaluating primary packaging for drug products one must evaluate the performance of the devices and the packaging to ensure that they are fit-for-purpose.
-
![GettyImages-155372946-cold-chain-cryopreservation-logistics]( "Optimized Laboratory Kitting Is Key To Successful Clinical Trials")
Optimized Laboratory Kitting Is Key To Successful Clinical TrialsClinical trials can be completely derailed by the absence of a single component, a lack of clarity in labelling, or errors in temperature-controlled logistics.
-
![GettyImages-1265108955 data]( "Level Up Your Supply Chain Initiatives")
Level Up Your Supply Chain InitiativesShipping and storing advanced therapeutics are complex processes, but advancements in accountability, wearables, and technology capture real-time factors critical to safety and protocol.
-
![An Insider’s Guide To Interactive Response Technology (IRT) For Clinical Trials]( "Modern Architecture's Impact On UX In Next-Gen Interactive Response Tech")
Modern Architecture's Impact On UX In Next-Gen Interactive Response TechExplore how Interactive Response Technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.
-
![iStock-1088247762-risk]( "Avoiding The Risk Of A Non-Transparent Clinical Supply Solution")
Avoiding The Risk Of A Non-Transparent Clinical Supply SolutionWith the supply chain and transportation logistics disruption caused by the COVID-19 pandemic, full documentation and complete transparency becomes even more important to avoid delays and assert provenance.
-
![iStock-486571129-supply-chain-logistics-packaging]( "Is Your Clinical Supply Strategy Ready For EU CTR?")
Is Your Clinical Supply Strategy Ready For EU CTR?One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging?
-
![Sperm-bank-GettyImages-1333952315]( "Cryobag Container Development For Cell & Gene Therapies")
Cryobag Container Development For Cell & Gene TherapiesISR Reports addresses the logistical challenges faced by developers of cell and gene therapies regarding cold chain and cryopreservation.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
